Chuyển Đổi Hệ Tiêu Hoá Một Tắc Nghẽn: Khác Biệt Khái Niệm Giữa Đông và Tây

Springer Science and Business Media LLC - Tập 31 - Trang 3296-3302 - 2021
Cong Li1, Shibo Lin1, Hui Liang1
1Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China

Tóm tắt

Chuyển đổi hệ tiêu hoá một tắc nghẽn (SADS) đang ngày càng trở nên phổ biến. Bài tổng quan này so sánh sự khác biệt khái niệm giữa các quốc gia phương Đông (SADS-E) và phương Tây (SADS-W). Sau khi tìm kiếm thông tin về SADS thông qua PubMed và các tạp chí uy tín, 19 bài viết với 2280 bệnh nhân đã được đưa vào phân tích. Chúng tôi nhận thấy SADS-W dành cho những bệnh nhân có chỉ số khối cơ thể (BMI) cao mà không mắc bệnh tiểu đường tuýp 2 (T2DM). Các bác sĩ phẫu thuật thực hiện SADS-W sử dụng ống thông lớn hơn và ưa thích các kênh chung ngắn hơn. Tuy nhiên, SADS-E chủ yếu được ưa chuộng ở bệnh nhân T2DM với BMI thấp. SADS-E đã bỏ qua ít ruột hơn và sử dụng ống thông nhỏ hơn. Các phổ biến biến chứng sau phẫu thuật chính, thiếu hụt dinh dưỡng, và rối loạn tiêu hóa cũng khác nhau giữa SADS-E và SADS-W. SADS-W mang lại giảm cân tốt hơn và tỷ lệ phục hồi T2DM tốt hơn so với SADS-E. SADS là các thủ tục bariatric và chuyển hóa hiệu quả với kết quả điều trị đầy hứa hẹn và an toàn chấp nhận được.

Từ khóa

#SADS #chuyển đổi hệ tiêu hoá #bệnh tiểu đường tuýp 2 #chỉ số khối cơ thể #biến chứng sau phẫu thuật

Tài liệu tham khảo

Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014;384(9945):766–81. Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric surgery versus intensive medical therapy for diabetes — 5-year outcomes. N Engl J Med. 2017;376:641–51. Angrisani L, Santonicola A, Iovino P, et al. IFSO Worldwide Survey 2016: primary, endoluminal, and revisional procedures. Obes Surg. 2018;28:3783–94. Hans PK, Guan W, Lin S, et al. Long-term outcome of laparoscopic sleeve gastrectomy from a single center in mainland China. Asian J Surg. 2018;41:285–90. Yu J, Zhou X, Li L, et al. The long-term effects of bariatric surgery for type 2 diabetes: systematic review and meta-analysis of randomized and non-randomized evidence. Obes Surg. 2015;25:143–58. Lin S, Guan W, Yang N, et al. Short-term outcomes of sleeve gastrectomy plus jejunojejunal bypass: a retrospective comparative study with sleeve gastrectomy and Roux-en-Y gastric bypass in Chinese patients with BMI ≥ 35 kg/m2. Obes Surg. 2019;29:1352–9. Sánchez-Pernaute A, Rubio Herrera MA, Pérez-Aguirre E, et al. Proximal duodenal–ileal end-to-side bypass with sleeve gastrectomy: proposed technique. Obes Surg. 2007;17:1614–8. Angrisani L, Santonicola A, Iovino P, et al. IFSO Worldwide Survey 2016: primary, endoluminal, and revisional procedures. Obes Surg. 2018;28:3783–94. PMID: 30121858 Brown WA, de Leon Ballesteros GP, Ooi G, et al. Single anastomosis duodenal-ileal bypass with sleeve gastrectomy/one anastomosis duodenal switch (SADI-S/OADS) IFSO Position Statement—Update 2020. Obes Surg. 2021;31:3–25. PMID: 33409979 Kallies K, Rogers AM. American Society for Metabolic and Bariatric Surgery updated statement on single-anastomosis duodenal switch. Surg Obes Relat Dis. 2020;16:825–30. Lin S, Yang N, Guan W, et al. Can Chinese T2D patients with BMI 20–32.5 kg/m2 benefit from loop duodenojejunal bypass with sleeve gastrectomy? Surg Obes Relat Dis. 2019;15:1513–9. Ser K, Lee W, Chen J, et al. Laparoscopic single-anastomosis duodenal-jejunal bypass with sleeve gastrectomy (SASADI-S-E): surgical risk and long-term results. Surg Obes Relat Dis. 2019;15:236–43. Huang CK, Tai C, Chang P, et al. Loop duodenojejunal bypass with sleeve gastrectomy: comparative study with Roux-en-Y gastric bypass in type 2 diabetic patients with a BMI <35 kg/m2, first year results. Obes Surg. 2016;26:2291–301. Ruan X, Zhang W, Cai H, et al. Sleeve gastrectomy with duodenojejunal end-to-side anastomosis in the treatment of type 2 diabetes: the initial experiences in a Chinese population with a more than 4-year follow-up. Surg Obes Relat Dis. 2017;13:1683–91. Vennapusa A, Panchangam RB, Kesara C, et al. Factors predicting weight loss after “sleeve gastrectomy with loop duodenojejunal bypass” surgery for obesity. J Obes Metab Syndr. 2020;29:208–14. Gebelli JP, Gordejuela AG, Ramos AC, et al. SADI-S with right gastric artery ligation: technical systematization and early results. Arq Bras Cir Dig. 2016;29(Suppl 1):85–90. Sanchez-Pernaute A, Rubio MA, Cabrerizo L, et al. Single-anastomosis duodenoileal bypass with sleeve gastrectomy (SADI-S) for obese diabetic patients. Surg For Obes Relat Dis. 2015;11:1092–8. Nelson L, Moon RC, Teixeira AF, et al. Safety and effectiveness of single anastomosis duodenal switch procedure: preliminary result from a single institution. ABCD Arq Brasil Cirurgia Digest. 2016;29:80–4. Sanchez-Pernaute A, Rubio MA, Antona EM, et al. Single-anastomosis duodeno-ileal bypass with sleeve gastrectomy (SADI-S) absolute results at 5 years. Surg Obes Relat Dis. 2016;12 Andalib A, Bouchard P, Alamri H, et al. Single anastomosis duodeno-ileal bypass with sleeve gastrectomy (SADI-S): short-term outcomes from a prospective cohort study. Surg Obes Relat Dis. 2020 Sep;14:S1550–7289. Yashkov Y, Bordan N, Torres A, et al. SADI-S 250 vs Roux-en-Y duodenal switch (RY-DS): results of 5-year observational study. Obes Surg. 2020 Oct;12 Zaveri H, Surve A, Cottam D, et al. Mid-term 4-year outcomes with single anastomosis duodenal-ileal bypass with sleeve gastrectomy surgery at a single US center. Obes Surg. 2018;28:3062–72. Surve A, Rao R, Cottam D, et al. Early outcomes of primary SADI-S: an Australian experience. Obes Surg. 2020;30:1429–36. Cottam D, Roslin M, Enochs P, et al. Single anastomosis duodenal switch: 1-year outcomes. Obes Surg. 2020;30:1506–14. Enochs P, Bull J, Surve A, et al. Comparative analysis of the single-anastomosis duodenal-ileal bypass with sleeve gastrectomy (SADI-S) to established bariatric procedures: an assessment of 2-year postoperative data illustrating weight loss, type 2 diabetes, and nutritional status in a single US center. Surg Obes Relat Dis. 2020;16:24–33. Neichoy BT, Schniederjan B, Cottam DR, et al. Stomach intestinal pylorus-sparing surgery for morbid obesity. JSLS : J Soc Laparoendos Surg. 2018;22:e2017–63. Mitzman B, Cottam D, Goriparthi R, et al. Stomach intestinal pylorus sparing (SIPS) surgery for morbid obesity: retrospective analyses of our preliminary experience. Obes Surg. 2016;26:2098–104. Sabrudin S, Goriparthi R, Lamoureux D, et al. Modified duodenal switch (MDS) or SIPS (stomach intestine pyloric sparing) results and significance. Surg Obes Relat Dis. 2016;12:S75. Surve A, Zaveri H, Cottam D, et al. A retrospective comparison of biliopancreatic diversion with duodenal switch with single anastomosis duodenal switch (SIPS-stomach intestinal pylorus sparing surgery) at a single institution with two year follow-up. Surg Obes Relat Dis. 2017;13:415–22. Surve A, Cottam D, Sanchez-Pernaute A, et al. The incidence of complications associated with loop duodeno-ileostomy after single-anastomosis duodenal switch procedures among 1328 patients: a multicenter experience. Surg Obes Relat Dis. 2018;14:594–601. PMID: 29530597 Surve A, Cottam D, Medlin W, et al. Long-term outcomes of primary single-anastomosis duodeno-ileal bypass with sleeve gastrectomy (SADI-S). Surg Obes Relat Dis. 2020;16:1638–46. PMID: 32843266 Surve A, Cottam D, Richards C, et al. A matched cohort comparison of long-term outcomes of Roux-en-Y gastric bypass (RYGB) versus single-anastomosis duodeno-ileostomy with sleeve gastrectomy (SADI-S). Obes Surg. 2020; PMID: 33201398 Buse JB, Caprio S, Cefalu WT, et al. How do we define cure of diabetes? Diabetes Care. 2009;32:2133–5. Lee W, Almulaifi AM, Tsou J, et al. Duodenal–jejunal bypass with sleeve gastrectomy versus the sleeve gastrectomy procedure alone: the role of duodenal exclusion. Surg Obes Relat Dis. 2015;11:765–70. Cheng Y, Huang X, Wu D, et al. Sleeve gastrectomy with bypass of proximal small intestine provides better diabetes control than sleeve gastrectomy alone under postoperative high-fat diet. Obes Surg. 2019;29:84–92. Takayama H, Ohta M, Tada K, et al. Additional effects of duodenojejunal bypass on glucose metabolism in a rat model of sleeve gastrectomy. Surg Today. 2019;49:637–44.